Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N05 PSYCHOLEPTICS
N05B ANXIOLYTICS
N05BA Benzodiazepine derivatives
N05BA12 Alprazolam
D00225 Alprazolam (JP18/USP/INN) <JP/US>
USP drug classification [BR:br08302]
Anxiolytics
Benzodiazepines
Alprazolam
D00225 Alprazolam (JP18/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
11 Agents affecting central nervous system
112 Hypnotics and sedatives, anxiolytics
1124 Benzodiazepins
D00225 Alprazolam (JP18/USP/INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01567 GABA-A receptor agonist
D00225 Alprazolam
DG01914 Anxiolytics, benzodiazepine derivatives
D00225 Alprazolam
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
D00225 Alprazolam
Target-based classification of drugs [BR:br08310]
Ion channels
Ligand-gated ion channels
GABA (ionotropic)
GABR
D00225 Alprazolam (JP18/USP/INN) <JP/US>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00225 Alprazolam
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D00225
Narcotics and psychotropics in Japan [br08308.html]
Psychotropics by Cabinet order Article 3 (78 substances)
D00225